Pathomic immune biomarkers define recurrence risk in early-stage melanoma is a research paper published in The Oncologist (2025). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Intramural NIH HHS
Grant: Z01 HD008845
NCI NIH HHS
Grant: R01 CA260375
NIH HHS
National Institutes of Health
FWCI
1.02
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords